Pancreas preservation in extracellular-type p38 inhibitor-containing solution improves islet yield for porcine islet isolation
- PMID: 33231337
- DOI: 10.1111/xen.12661
Pancreas preservation in extracellular-type p38 inhibitor-containing solution improves islet yield for porcine islet isolation
Abstract
Background: For islet transplantation, pancreas preservation and islet isolation activate p38, which is a member of the stress-activated group of mitogen-activated protein kinases (MAPKs). In this study, we evaluated an extracellular-type p38 inhibitor-containing (EP) solution with University of Wisconsin (UW) solution, the gold standard for organ preservation. The EP solution has high sodium-low potassium composition with low viscosity compared to UW solution. Moreover, EP solution contains a recently developed p38 inhibitor (11R-p38I110 ) from our laboratory.
Methods: Porcine pancreata were preserved in UW, EP, or EP-P solution (EP solution without 11R-p38I110 ), and then islet isolation was performed. An optimized number (1500 IE) of isolated islets from each group were transplanted into streptozotocin-induced diabetic mice.
Results: The islet yield before and after purification was significantly higher in the EP group than in the UW group. The islet yield before and after purification was not significantly different between the EP and EP-P groups; however, the EP solution prevented a reduction in the number of islets during culture. Western blot analysis showed that p38 activation was attenuated by EP solution. For islet transplantation into streptozotocin-induced diabetic mice, pancreas preservation in EP solution improved the outcome of islet transplantation.
Conclusions: Pancreas preservation with EP solution preserved islet function better than with UW solution. The advantages of EP solution over UW solution may include the inhibition of p38 activity as well as the composition of the solution.
Keywords: 11R-p38I110; islet transplantation; p38 MAPK; pancreas preservation; porcine pancreas.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Pancreas Preservation in Modified Histidine-lactobionate Solution Is Superior to That in University of Wisconsin Solution for Porcine Islet Isolation.Transplantation. 2022 Sep 1;106(9):1770-1776. doi: 10.1097/TP.0000000000003636. Epub 2021 Feb 5. Transplantation. 2022. PMID: 36001489
-
A Novel Preservation Solution Containing a JNK Inhibitory Peptide Efficiently Improves Islet Yield for Porcine Islet Isolation.Transplantation. 2019 Feb;103(2):344-352. doi: 10.1097/TP.0000000000002555. Transplantation. 2019. PMID: 30557272
-
Preservation of pancreas in the University of Wisconsin solution supplemented with AP39 reduces reactive oxygen species production and improves islet graft function.Am J Transplant. 2021 Aug;21(8):2698-2708. doi: 10.1111/ajt.16401. Epub 2020 Dec 25. Am J Transplant. 2021. PMID: 33210816
-
Pancreas preservation by the two-layer method: does it have a beneficial effect compared with simple preservation in University of Wisconsin solution?Cell Transplant. 2009;18(5):497-503. doi: 10.1177/096368970901805-603. Cell Transplant. 2009. PMID: 19775509 Review.
-
Pancreas preservation for pancreas and islet transplantation: a minireview.Transplant Proc. 2011 Nov;43(9):3398-401. doi: 10.1016/j.transproceed.2011.09.052. Transplant Proc. 2011. PMID: 22099806 Review.
Cited by
-
Clinical Islet Transplantation Covered by Health Insurance in Japan.J Clin Med. 2022 Jul 8;11(14):3977. doi: 10.3390/jcm11143977. J Clin Med. 2022. PMID: 35887740 Free PMC article.
-
Adhesion Characteristics of Human Pancreatic Islets, Duct Epithelial Cells, and Acinar Cells to a Polymer Scaffold.Cell Transplant. 2022 Jan-Dec;31:9636897221120500. doi: 10.1177/09636897221120500. Cell Transplant. 2022. PMID: 36062469 Free PMC article.
References
REFERENCES
-
- Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
-
- Ricordi C, Goldstein JS, Balamurugan AN, et al. National institutes of health-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities. Diabetes. 2016;65:3418-3428.
-
- Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2016;39:1230-1240.
-
- Foster ED, Bridges ND, Feurer ID, Eggerman TL, Hunsicker LG, Alejandro R. Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2018;41:1001-1008.
-
- Noguchi H, Ueda M, Nakai Y, et al. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am J Transplant. 2006;6:496-504.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical